Ajanta Pharma

Presented By:
Srushti Borade
PM-16-06
IES MCRC

1
 Introduction
AjantaPharma Limited (APL)
(BSE: 532331 | NSE: AJANTPHARM) Is an Indian
multinational, engaged in development, manufacturing and
marketing of pharmaceutical formulations

It has presence inIndia,USAand about 30 Emerging countries

includingAfrica, Philippines, Rest of Asia, Middle East and CIS.
Ajanta started with re-packing of generic productsin 1973
1,400 products registered

7 manufacturing facilities; 6 within India and 1 in Mauritius

6,445 Employees

2
 Major Brands..
Ajanta Pharmas expertise covers a broad spectrum of products targeting
various diseases. Some of its major brands targeting diseases are
1. Anti-Malarials (Artefan Artemether & Lumefentrine)
2. Cardiology (Met XL Metoprolol Succinate)
3. Dermatology (Melacare Hydroquinone, Tretinoin, Mometasone)
4. Gastroenterology (Lafutax Lafutidine)
5. Musculoskeletal (Feburic Febuxostat)
6. Ophthalmology (Unibrom Bromfenac)
7. Respiratory (Fivasa Fluticasone Furoate Nasal Spray)

3
 Serve Health Care Needs
Vision Worldwide

Our mission is to Serve Global Healthcare needs

through Empathy, Innovation and

Mission Technology. We believe that to ensure sustained

growth, we need to clearly understand our
customers needs and use cutting edge technology
to present innovative solutions.

4
Board of Directors

5
 Strategy Statement
To be present in the right markets with differentiated,
difficult to produce products, To create impacts and
optimize opportunities across geographies.

6
 Strengthening
presence in
India

Building Country
Strategies specific and
USA product
market specific model

Scientifically
driven R & D
7
 Strengthening presence in India:
Continue innovation
Strengthen leadership in therapeutic segments
Enhance sales force productivity

Country specific and product specific model: (Products were developed on the basis of
unmet needs in a particular geography)
The company does not sale all its products in all the geographies in which it operates.
Rather it follows a very country specific and product specific model.
For example, it sells its Anti malarial products and specialty range of products in African
markets which continue to do wonder,
while in South East Asian markets, cardiology, ophthalmology and dermatology products
are sold.
Similarly for Latin American market, the company has cuff syrup dosages.
Thus rather than dumping all the products to marketing team, products or rather, the
brands are sold depending upon the demand for that particular market.

8
 Building USA market
Quick launch of approved products
Enhance customers supply chain experience
File 12-15 ANDAs to create a strong pipeline

Scientifically driven R & D:

Companys strategy is centered on improving the speed and yield of

generic products.
Invested 8% of its total operating income on R & D and continues to build
support infrastructure.

9
 Objective

To augment our differentiated product portfolio

further and offer impactful solutions (backed by
intensive and extensive research) for speciality
therapeutic segments.

10
 Competencies
Core Competencies
R and D + Human assets:

R & D: Cornerstone of innovation at Ajanta Pharma

A team of 800+ well qualified and experienced professionals, specialized

across value chain of pharmaceutical research

11
THANK
YOU!!
12